We are live on ! Find out more
KPRX icon

Kiora Pharmaceuticals
KPRX

12 hedge funds and large institutions have $10.1M invested in Kiora Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

0% more funds holding

Funds holding: 12 → 12 (0)

0.05% less ownership

Funds ownership: 0.17% → 0.12% (-0.05%)

55% less capital invested

Capital invested by funds: $22.4M → $10.1M (-$12.3M)

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
Armistice Capital
New York
+$138K
2
Renaissance Technologies
Renaissance Technologies
New York
+$133K
3
GSWM
Golden State Wealth Management
California
+$10.8K
4
Victory Capital Management
Victory Capital Management
Texas
+$8.61K
5
Bank of America
Bank of America
North Carolina
+$4.3K

Top Sellers

1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$3.29M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$5K
3
VFA
Valeo Financial Advisors
Indiana
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$9.44M +$138K +64 +1%
Renaissance Technologies
2
Renaissance Technologies
New York
$287K +$133K +62 +68%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$179K +$4.3K +2 +2%
BlackRock
4
BlackRock
New York
$136K – – –
US Bancorp
5
US Bancorp
Minnesota
$14K – – –
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$9K – – –
GSWM
7
Golden State Wealth Management
California
$9K +$10.8K +5 New
Victory Capital Management
8
Victory Capital Management
Texas
$8K +$8.61K +4 New
UBS Group
9
UBS Group
Switzerland
$7K +$4.3K +2 +100%
Bank of America
10
Bank of America
North Carolina
$4K +$4.3K +2 New
Osaic Holdings
11
Osaic Holdings
Arizona
$4K +$4.3K +2 New
Morgan Stanley
12
Morgan Stanley
New York
$2K – – –
Hudson Bay Capital Management
13
Hudson Bay Capital Management
Connecticut
– -$3.29M -912 Closed
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
– -$5K -1 Closed
VFA
15
Valeo Financial Advisors
Indiana
– -$1K – –

KPRX Hedge Fund Activity: Q1 2020 in Review

12 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q1 2020, worth a combined $10.1M — down 55% from $22.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new KPRX positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, adding an estimated $138K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $3.29M sold.

  • 12 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $10.1M of Kiora Pharmaceuticals stock for Q1 2020, down 55% quarter-over-quarter.
  • 4 funds opened new Kiora Pharmaceuticals positions in Q1 2020 and 2 closed out, a net change of +2 holders.
  • The largest Kiora Pharmaceuticals buyer in Q1 2020 was Armistice Capital, an estimated $138K added.
  • The largest Kiora Pharmaceuticals seller in Q1 2020 was Hudson Bay Capital Management, an estimated $3.29M sold.

Based on aggregated 13F filings for Q1 2020.